A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx
-
Upload
bsulejma09 -
Category
Documents
-
view
551 -
download
0
Transcript of A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx
![Page 1: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/1.jpg)
A REVIEW OF BEST PRACTICES IN
VASCULAR ACCESS AND INFUSION THERAPY
PRESENTER
JOSEPH PETTEE RN BSN CRNI VA-BC
President/CEO AccessRN, Inc.
![Page 2: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/2.jpg)
Disclosure
CEO and FOUNDER for AccessRNASSOCIATION OF VASCULAR ACCESS
FOUNDATION BOARD MEMBERCONSULTANT BARD MEDICAL
CONSULTANT GENETECH MEDICALCONSULTANT ARGON MEDICAL
CONSULTANT ANALOGIC MEDICAL
![Page 3: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/3.jpg)
Why is this Important
To me?I’m an administrator, why do I need to
know about IV’s and IV meds?I work in dietary, why do I need to know….I don’t even work with patients, why do I
need to know……
![Page 4: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/4.jpg)
One day……You may……
…be the patient!
![Page 5: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/5.jpg)
![Page 6: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/6.jpg)
Objectives1. To gain knowledge of vein anatomy,
principles of infusions, and vascular access devices.
2. To understand vessel health and preservation to provide best outcomes for residents by decreasing complications.
3. To gain knowledge on building a successful infusion program decreasing complications and increasing profits.
4. To understand new controversial research and its impact on the care you provide
5. Understand new technology and its impact on the PT
![Page 7: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/7.jpg)
Vein Anatomy
1. Tunica Intima-inside, one cell layer thick, keeps vein “water tight”.2. Tunica Media-middle, muscles, connective tissue.3. Tunica Adventitia-outside, sympathetic and afferent nerve endings.
![Page 8: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/8.jpg)
Principles of Infusion1. Hemodilution-the more blood mixes
the less harmful medicines are to veins
2. Right line at the Right time3. Site selection is imperative4. One patient, one stick, one device
![Page 9: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/9.jpg)
Hemodilution1. Hand veins 30-40 ml per minute2. Forearm veins 50-60 ml per minute3. Axillary veins 200-300 ml per minute4. Subclavian vein 700 -800 ml per
minute5. Lower third of SVC or Cavoatrial
Junction 2000-2500 ml per minute
![Page 10: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/10.jpg)
Right line at the Right Time1. What is the prescribed therapy?2. What is the duration of therapy?3. What vein options does the patient
have?4. What are the available devices?5. What is the vascular access skill level
of the clinician that is available to place the line?
6. What is the competency of the bedside nurse that accepts responsibility for the patient?
![Page 11: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/11.jpg)
Chose a device!1. Short peripheral intravenous catheter (PICV)2. Long PICV3. Short Midline4. Long Midline5. PICC6. CVC7. JACC8. Tunneled catheter9. Implantable port10. Power injectable11. Valve or non-valve12. Positive pressure, neutral pressure, negative pressure- needleless
connectors13. Antibiotic impregnated14. Antimicrobial coated15. Do we use Ultrasound guidance, b mode, c mode, in-plane, out of plane,
sagittal, longitudinal16. Modified seldingers, microintroducer, steal needle, angiocath, nitinol,
platinum or stainless steal, 17. Will we verify the tip with CXR or EKG?
![Page 12: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/12.jpg)
One Patient,
One Stick,
One Device!
![Page 13: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/13.jpg)
How many times do we stick?
How many nurses get to try?
As many as it takes?
What’s your policy?
How about 22 times?
![Page 14: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/14.jpg)
Complications1. Phlebitis2. Infiltration/Extravasation3. Infection4. Hematoma/Arterial Puncture5. Nerve damage6. Embolism7. Thrombosis8. Catheter malposition9. Catheter occlusion
![Page 15: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/15.jpg)
Phlebitis
![Page 16: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/16.jpg)
Venous Depletion
![Page 17: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/17.jpg)
Extravasation
![Page 18: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/18.jpg)
Extravasation
![Page 19: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/19.jpg)
Catheter Malposition
![Page 20: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/20.jpg)
Cavoatrial Junction: Optimal
![Page 21: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/21.jpg)
Decreasing Patient and Facility Complications1. Develop an infusion program with specially train
nurses and specific policies and procedures, IV resource personnel
2. ResourcesA. Infusion Nurse’s Society standards of practice,policy and procedure manual and position
statements (ins1.org)B. Association of Vascular Access position
statements (avainfo.org)C. CDC Guidelines for the Prevention of
Intravascular Catheter-Related InfectionsD. Pharmacies
E. Independent Vascular Access TeamsF. Nursing Competency
![Page 22: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/22.jpg)
Managing Infusion Program1. Assess Nurse’s ability2. Educate where knowledge deficits
exist3. Annual competencies4. Market services to referral sources5. Discuss appropriate vascular access
device at admission to LTC from ACH6. Promote your readmission rates
![Page 23: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/23.jpg)
Why infusion programs fail?1. Accessing veins is a Low volume
procedure in LTC2. Many devices with many purposes3. Care and maintenance Knowledge
deficit among nursing staff4. Residents are becoming venous
depleted
![Page 24: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/24.jpg)
Financial BreakdownResident with Medicare Part A
Unable to establish access in house
1. Ambulance ranges from $1000 to $1600 one way.2. Line insertion-$1200 to $20003. If patient stays at hospital $400-$600 per day lost in revenue to LTC 4. Not to mention the Hospital’s major focus on preventing 30 day readmission penalty
![Page 25: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/25.jpg)
Average Cost of sending patient out for line placement
Ambulance ride round trip $1100Line placement$1200
Total cost average $2300
Add an over night stay (loss) $400
Total cost $2700
![Page 26: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/26.jpg)
Combat Cost1. Assuring your nurses can care for
residents with vascular access devices.
2. Planning for the appropriate device that will carry the IV infusion for the entire length of therapy.
3. Maintain control over your patients by keeping your residents in your building!!!!
![Page 27: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/27.jpg)
Bedside Nurses And
Vascular Access
![Page 28: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/28.jpg)
Infusion Nurse’s Society Standards of Practice
Site selection 1. Avoid areas of flexion2. Largest vein and smallest catheter3. Avoid 4-5 inches on lateral surface of wrist4. Avoid lower extremities5. Avoid upper extremities in CKD 3,4,5 and
end stage.
![Page 29: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/29.jpg)
LEGALLY SPEAKING!!IF NO BLOOD RETURN DO NOT USE THE LINE UNTIL
YOU HAVE FLUSHES EASILY AND GOOD BLOOD RETURN
AND BE SURE TO DOCUMENT IN YOUR PROGRESS NOTES
![Page 30: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/30.jpg)
Vascular Access DevicesAnd Blood Return
• SOP 61 B “The nurse should aspirate for a positive blood return…to confirm patency”
• SOP 45 E “…as a component of assessing catheter function”
• SOP 45 G “…no blood return noted, further steps should be taken to assess patency”
![Page 31: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/31.jpg)
Flushing• Heparin vs Saline• Evidence to support both• SOP 45 J “short peripheral…
preservative free saline”• SOP 45 O “…central devices heparin
lock 10u/ml” recommended
![Page 32: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/32.jpg)
Peripheral Site Rotation• SOP 44 1 A “Replacement of short
peripheral catheter when clinically indicated”
• CDC “no more frequent than 72-96 hours”
![Page 33: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/33.jpg)
Occluded PICC’s
• Know your end cap• Proper flushing techniques• Monitor for early signs of occlusions• Catheter clearance; Declotting
![Page 34: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/34.jpg)
Migration of Catheter
• Resident pulls catheter out• Dislodged with dressing change• DONOT ATTEMPT TO REINSERT
![Page 35: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/35.jpg)
PICC vs MidlinePICC Midline
Hemodilution 2000-2500ml/min200-300ml/minCost Needs x-ray No x-ray neededInfusate Any *No Vesicant/IrritantsDuration Up to a year 29 days per IFUOccluded Can use Cathflo Not FDA approved
For CathfloPlacement Ultrasound Ultrasound
*Further discussion needed
![Page 36: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/36.jpg)
Irritants and VesicantsThrough Midlines?
• INS SOP 32 “Therapies not appropriate for midline catheters….pH less than 5 and greater than 9”
![Page 37: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/37.jpg)
New studySafe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical
trial
• Small sample size 30 catheters• Less than 5 days• Concentration of 4mg/ml
Conclusions: Short-term intravenous vancomycin can be safely and cost-efficiently administered in
the deep vessels of the upper arm using the midline study device
J Vasc Access 2014;15 (4): 251-256
![Page 38: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/38.jpg)
NEED MORE DATA!!!!!• Multicenter • Tracking outcomes for Midline
infusions• Matt Gibson 270-577-6159• [email protected]
![Page 39: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/39.jpg)
PICC Tip Location
6cm4cm2cm
86%
31%
1.2%
14%16%
Petersen et al, Am J Surg 1999, 178: 38-41
![Page 40: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/40.jpg)
PICC Tip Location
• INS Lower third SVC/CAJ• CDC Lower third SVC• NKF Lower third SVC• AVA Lower third SVC/CAJ• SIR Lower third SVC
Malpositioned if tip other locations A PICC catheter cut to a midline length is not used correctly. IFU advises SVC.
![Page 41: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/41.jpg)
DIVA’s(Difficult IntraVenous Access)
• Chronic diseases• Elderly vascular changes• Genetics• Frequent hospitalizations• Anticoagulants
What is it like for the bedside nurse to deal with the DIVA’s?
![Page 42: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/42.jpg)
• Multiple sticks• Frustration• Time consuming• Suboptimal sight
selection• Medication delays
![Page 43: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/43.jpg)
![Page 44: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/44.jpg)
Summary• One patient, One stick, One device• Place the best device first• Proper care and maintenance• CATHETER SHALL BE SMALLEST GUAGE
AND LENGTH AND FEWEST LUMENS • Keep device in patient• Keep patient in facility• Track outcomes• Partner with experts
![Page 45: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/45.jpg)
SUMMARY (CONTINUED)MEDICATION PH ALONE IS NOT A
CONTRAINDICATION FOR A MIDLINE THERE IS A GROWING BODY OF EVIDENCE TO SUPPORT A MORE
COMPREHENSIVE ASSESSMENT IN DETERMINING ACCESS TYPE AND
TYPE AND NUMBER OF INFUSATES DURATION OF THERAPY,LOCATION OF CATHETER, CONDITION OF PT’S
VEINS
![Page 46: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/46.jpg)
VASCULAR ACCESS DECISION TREEDETERMINE PT’S VENOUS ACCESS NEEDS EARLY
DETERMINE LENGTH AND TYPE OF THERAPY INDICATED
LESS THAN 7 DAYS MORE THAN 7 DAYS
NO YES
LENGTH PLA
> 10% DEXTROSE>5% PROTEINVESICANT OR KNOWN IRRITANTANTINEOPLASTICCONSIDER IF MEDICATION PH < 5 OR>9OSMOLALITY >600
YESPLACE CVA/PI
CC
NO YESLENGTH OF THERAPY 7-28 DAY
PLACE MIDLINE
LENGTH 7-365 PLACE
PICC
CONSIDER MIDLINE OR PIV ULTRASOUND FOR
PLACEMENT (ULTRASOUND TRAINED NURSE,PICC NURSE RN OR CONTRACT HITECH
VASCULAR TEAM
CONTACTNEXT LEVEL EXPERT FOR
LINE INITIATION
START PIVIF UNSUCCESSFUL AFTER 2 ATTEMPTS (HX OF DIFFICULT
ACCESS , OBESITY, OR EDEMA TO UPPER
EXTREMITY
![Page 47: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/47.jpg)
![Page 48: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/48.jpg)
![Page 49: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/49.jpg)
![Page 50: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/50.jpg)
![Page 51: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/51.jpg)
OPTIMAL PATIENT OUTCOMES DURING PICC PLACEMENT USING BED SIDE
CATHETER NAVIGATION AND CATHETER FDA APPROVED TIP COMFIRMATION
IMPROVES PATIENT SAFETY
MALPOSITIONS AND REPOSITIONSOF PICC TIP NO MORE GAMMA SCATTER RADIATION
REDUCE NEED TO TRANPORT PATIENT S REDUCE TIME TO INITATE IV THERAPY REDUCE REPEAT PROCEDURES COST EFFECTIVE (NO XRAY NEEDED)
![Page 52: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/52.jpg)
![Page 53: A review of Best Practices in Vascular Access and Infusion Therapy presentation 8-7-15.pptx](https://reader035.fdocuments.net/reader035/viewer/2022070512/5899c9041a28ab45548b697b/html5/thumbnails/53.jpg)